DoW Traumatic Brain Injury and Psychological Health, Translational Research Award | HT942526TBIPHRPTRA

DoW Traumatic Brain Injury and Psychological Health, Translational Research Award (TRA): FAQs

1) What is the Traumatic Brain Injury and Psychological Health, Translational Research Award (TRA)?

The TRA is a Defense Health Agency grant opportunity focused on translational research in traumatic brain injury (TBI) and psychological health. Its purpose is to move promising research beyond the lab and closer to real-world clinical use by turning strong scientific findings into practical tools, approaches, or products that can improve clinical care and patient outcomes.

2) What is the main goal of this award?

The core goal is translation: converting mature scientific findings into tangible and clinically meaningful deliverables (such as tools, interventions, workflows, or other products) that are positioned for the next stage of clinical readiness.

3) What types of projects are a good fit for this program?

Projects that are intentionally innovative and aimed at meaningful improvements in clinical care for TBI and/or psychological health. The program emphasizes work that advances mature concepts toward practical application, rather than small refinements of existing standards of care.

4) What types of projects are not a good fit?

Projects that only make incremental, low-impact tweaks to existing standards of care without a clear path to major improvement are not considered a good fit for this mechanism.

5) Is basic research allowed under this award?

No. Basic research is explicitly prohibited under the TRA.

6) Are clinical trials allowed under this award?

No. Clinical trials are also prohibited under this mechanism.

7) If clinical trials are prohibited, where does this award fit in the research pipeline?

This award is positioned in the middle-to-late translational space: beyond discovery science (basic research) but not yet running full clinical trials. It is meant to mature and evaluate concepts so they are ready for first-in-human studies or later clinical trials under a different funding mechanism.

8) Are preliminary data required?

Yes. Preliminary data are required, reflecting the expectation that applicants can provide credible evidence that the underlying idea works and is ready for refinement and/or rigorous clinical-readiness evaluation.

9) What are the research levels and why do they matter?

Funding is organized into two Research Levels. Applicants must choose the level that matches the maturity and scope of their project. Level selection should align with whether the project is focused on creating/refining a tangible product (Level 1) or conducting rigorous evaluation to prepare for first-in-human studies or later trials (Level 2).

10) What is Research Level 1 designed to support?

Research Level 1 supports taking mature ideas and shaping them into tangible and knowledge products that can later be tested more rigorously. Examples mentioned include refining a prototype, developing an intervention package, creating or improving an assessment tool, building implementation-ready workflows, or producing other concrete deliverables intended for subsequent evaluation.

11) What is Research Level 2 designed to support?

Research Level 2 supports rigorous evaluation of tangible or knowledge products with the explicit purpose of preparing them for first-in-human studies or eventual clinical trials. While Level 2 is intended to build the evidence base and readiness package needed to justify the next step, it still may not include clinical trials under this award.

12) Can an application include animal research?

Yes, but if an application involves animal research, it must clearly justify the animal model selection and explain how the model maps onto the human clinical condition. This is meant to keep animal work directly informative for real human TBI and psychological health needs.

13) Can an application include prospectively enrolling human subjects?

Yes, but if the proposed work prospectively enrolls human subjects, the application must incorporate community-based participatory research (CBPR) approaches.

14) What does the CBPR requirement mean for human subject enrollment?

The program requires meaningful involvement of affected communities and relevant stakeholders in the research process when human subjects will be prospectively enrolled. This is intended to improve relevance, feasibility, trust, and the likelihood that resulting products or approaches will be adopted in real care settings.

15) Is there an Early-Career Investigator Partnering Option?

Yes. The award offers an Early-Career Investigator Partnering Option at both Research Level 1 and Research Level 2.

16) How does the Early-Career Investigator Partnering Option work?

Under this option, two Principal Investigators (PIs) may lead the project together, with one PI qualifying as an Early-Career Investigator. If selected for funding, each PI receives a separate award. This structure is intended to support mentorship and capacity-building while enabling shared leadership and ensuring clear resources and recognition for the early-career partner.

17) Who is the awarding agency for this opportunity?

The opportunity is offered by the Defense Health Agency Contracting Activity (DHACA) as a discretionary grant in the science and technology/research and development category.

18) What is the CFDA number associated with this program?

The CFDA number listed for this opportunity is 12.420.

19) What is the opportunity number?

The opportunity number is HT942526TBIPHRPTRA.

20) What is the eligibility for applicants?

Eligibility is listed as unrestricted, meaning a broad range of applicant organizations may apply, subject to standard federal requirements.

21) When was this opportunity created?

The opportunity was created on 2026-05-21.

22) What is the application closing date?

The original application closing date is 2026-10-15.

23) How many awards does the agency expect to make?

The agency anticipates making about six awards.

24) What is the maximum award amount (award ceiling)?

An award ceiling is referenced in the listing, but the specific ceiling amount is not provided in the supplied information.

25) Does this award focus more on innovation or incremental improvements?

This program is intentionally aimed at innovation. Proposals should show a clear path to major improvement in clinical care or outcomes rather than minor adjustments to existing practices.